Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Leukemia

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 32 articles:
HTML format



Single Articles


    February 2021
  1. PINTO-FERNANDEZ A, Salio M, Partridge T, Chen J, et al
    Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.
    Br J Cancer. 2021;124:817-830.
    PubMed     Abstract available


    January 2021
  2. BARROW TM, Nakjang S, Lafta F, Bilotkach K, et al
    Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia.
    Br J Cancer. 2021;124:474-483.
    PubMed     Abstract available


    December 2020
  3. PUETT RC, Poulsen AH, Taj T, Ketzel M, et al
    Relationship of leukaemias with long-term ambient air pollution exposures in the adult Danish population.
    Br J Cancer. 2020;123:1818-1824.
    PubMed     Abstract available


    October 2020
  4. GUILLEMETTE C, Rouleau M, Vanura K, Levesque E, et al
    Reply to Comment on "UGT2B17 modifies drug response in chronic lymphocytic leukaemia".
    Br J Cancer. 2020;123:1347-1348.
    PubMed    


  5. PAPAMICHOS SI, Jungbauer C
    Comment on: "UGT2B17 modifies drug response in chronic lymphocytic leukaemia".
    Br J Cancer. 2020;123:1345-1346.
    PubMed    


    September 2020
  6. SHIN AR, Lee SE, Choi H, Sohn HJ, et al
    An effective peptide vaccine strategy circumventing clonal MHC heterogeneity of murine myeloid leukaemia.
    Br J Cancer. 2020;123:919-931.
    PubMed     Abstract available


  7. ALRUWETEI AM, Bendak K, Yadav BD, Carol H, et al
    Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia.
    Br J Cancer. 2020;123:742-751.
    PubMed     Abstract available


    July 2020
  8. ALLAIN EP, Rouleau M, Vanura K, Tremblay S, et al
    UGT2B17 modifies drug response in chronic lymphocytic leukaemia.
    Br J Cancer. 2020;123:240-251.
    PubMed     Abstract available


    June 2020
  9. TOSCAN CE, Jing D, Mayoh C, Lock RB, et al
    Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression.
    Br J Cancer. 2020;122:1769-1781.
    PubMed     Abstract available


    May 2020
  10. LIU J, Hong J, Han H, Park J, et al
    Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration.
    Br J Cancer. 2020;122:1445-1452.
    PubMed     Abstract available


    April 2020
  11. YANG J, Meng C, Weisberg E, Case A, et al
    Inhibition of the deubiquitinase USP10 induces degradation of SYK.
    Br J Cancer. 2020;122:1175-1184.
    PubMed     Abstract available


  12. CREMER A, Stegmaier K
    Targeting DUBs to degrade oncogenic proteins.
    Br J Cancer. 2020;122:1121-1123.
    PubMed     Abstract available


    February 2020
  13. TAVAKOLI SHIRAZI P, Eadie LN, Heatley SL, Hughes TP, et al
    The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL.
    Br J Cancer. 2020;122:455-464.
    PubMed     Abstract available


    July 2019
  14. VISENTIN A, Bonaldi L, Rigolin GM, Mauro FR, et al
    The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
    Br J Cancer. 2019;121:150-156.
    PubMed     Abstract available


    May 2019
  15. CHEN X, Wang F, Zhang Y, Teng W, et al
    A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide.
    Br J Cancer. 2019;120:1023-1025.
    PubMed     Abstract available


    January 2019
  16. TOKAREW N, Ogonek J, Endres S, von Bergwelt-Baildon M, et al
    Teaching an old dog new tricks: next-generation CAR T cells.
    Br J Cancer. 2019;120:26-37.
    PubMed     Abstract available


    March 2018
  17. STRAHLENDORF C, Pole JD, Barber R, Dix D, et al
    Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study.
    Br J Cancer. 2018;118:744-749.
    PubMed     Abstract available


    February 2018
  18. DOSS M
    Comment on '30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure'.
    Br J Cancer. 2018 Feb 13. pii: bjc2017481. doi: 10.1038/bjc.2017.
    PubMed    


  19. HSIEH WH, Lin IF, Ho JC, Chang PW, et al
    Reply to 'Comment on '30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure''.
    Br J Cancer. 2018 Feb 13. pii: bjc2017490. doi: 10.1038/bjc.2017.
    PubMed    


  20. TAN L, Xu H, Chen G, Wei X, et al
    Silencing of HMGA2 reverses retardance of cell differentiation in human myeloid leukaemia.
    Br J Cancer. 2018;118:405-415.
    PubMed     Abstract available


    January 2018
  21. HWEE J, Tait C, Sung L, Kwong JC, et al
    A systematic review and meta-analysis of the association between childhood infections and the risk of childhood acute lymphoblastic leukaemia.
    Br J Cancer. 2018;118:127-137.
    PubMed     Abstract available


  22. SOEGAARD SH, Rostgaard K, Kamper-Jorgensen M, Schmiegelow K, et al
    Maternal diabetes and risk of childhood acute lymphoblastic leukaemia in the offspring.
    Br J Cancer. 2018;118:117-120.
    PubMed     Abstract available


    November 2017
  23. ISLAM M, Mohamed EH, Esa E, Kamaluddin NR, et al
    Circulating cytokines and small molecules follow distinct expression patterns in acute myeloid leukaemia.
    Br J Cancer. 2017;117:1551-1556.
    PubMed     Abstract available


    October 2017
  24. BINDELS LB, Porporato PE, Ducastel S, Sboarina M, et al
    Ffar2 expression regulates leukaemic cell growth in vivo.
    Br J Cancer. 2017;117:1336-1340.
    PubMed     Abstract available


  25. CASSIER PA, Castets M, Belhabri A, Vey N, et al
    Targeting apoptosis in acute myeloid leukaemia.
    Br J Cancer. 2017;117:1089-1098.
    PubMed     Abstract available


  26. HSIEH WH, Lin IF, Ho JC, Chang PW, et al
    30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure.
    Br J Cancer. 2017 Oct 3. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


    September 2017
  27. PIATOPOULOU D, Avgeris M, Marmarinos A, Xagorari M, et al
    miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.
    Br J Cancer. 2017;117:801-812.
    PubMed     Abstract available


    July 2017
  28. FORERO-CASTRO M, Robledo C, Benito R, Bodega-Mayor I, et al
    Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
    Br J Cancer. 2017;117:256-265.
    PubMed     Abstract available


    June 2017
  29. CHERNYAVSKIY P, Edmondson EF, Weil MM, Little MP, et al
    High-energy particle beam and gamma radiation exposure, familial relatedness and cancer in mice.
    Br J Cancer. 2017;117:41-50.
    PubMed     Abstract available


    January 2017
  30. FREDERIKSEN H, Farkas DK, Horvath-Puho E, Norgaard JM, et al
    Asthma and risk of myelodysplastic syndromes: a population-based cohort study.
    Br J Cancer. 2017;116:100-102.
    PubMed     Abstract available


  31. ANDERSEN KK, Duun-Henriksen AK, Frederiksen MH, Winther JF, et al
    Ninth grade school performance in Danish childhood cancer survivors.
    Br J Cancer. 2017;116:398-404.
    PubMed     Abstract available


  32. ROMANO M, Della Porta MG, Galli A, Panini N, et al
    Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.
    Br J Cancer. 2017;116:335-343.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: